Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy.

Pharmacogenetics and genomics - 1 Jan 2007

Pae Chi-Un, Serretti Alessandro, Mandelli Laura, De Ronchi Diana, Patkar Ashwin A, Jun Tae-Youn, Kim Jung-Jin, Lee Chang-Uk, Lee Soo-Jung, Lee Chul, Paik In-Ho

Abstract excerpt

OBJECTIVE: Antidepressant drug efficacy is partially under genetic control and a number of gene variants have been associated with antidepressants efficacy over the last few years. In the search for further genes influencing antidepressant response we focused on the dysbindin gene (dystrobrevin-b...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Carrier Proteins
Share to Depressive Disorder, Major

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dysbindin

Share to Dystrophin-Associated Proteins

Share to Psychiatric Status Rating Scales

Share to Selective Serotonin Reuptake Inhibitors

Source

Identifiers

PMID: 17264804
DOI: 10.1097/01.fpc.0000236330.03681.6d

Genes

DTNBP1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17264804-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dysbindin associated with selective serotonin reuptake inhibitor antidepressant efficacy.PMID 17264804Read ↗

Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors.Semantic proximity Read ↗

Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: lack of association with clinical phenotypes.Semantic proximity Read ↗

The dysbindin gene in major depression: an association study.Semantic proximity Read ↗

Genomic predictors of response to antidepressants in Major depressive disorder (MDD): A GWAS-Based Study on Indian cohortSemantic proximity Read ↗

Is there protective haplotype of dysbindin gene (DTNBP1) 3 polymorphisms for major depressive disorder.Semantic proximity Read ↗

Dysbindin (DTNBP1)--a role in psychotic depression?Semantic proximity Read ↗

Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder.Semantic proximity Read ↗

Genome-wide association studies of antidepressant outcome: a brief review.Semantic proximity Read ↗

Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients.Semantic proximity Read ↗

DISC1-TSNAX and DAOA genes in major depression and citalopram efficacy.Semantic proximity Read ↗

Whole-genome sequencing reveals KRTAP1-1 as a novel genetic variant associated with antidepressant treatment outcomes.Semantic proximity Read ↗

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.